TIMI 3A

TIMI IIIA evaluated the effect of rtPA vs. placebo on the culprit coronary lesion in patients with unstable angina or non-Q-wave myocardial infarction.

MAIN RESULTS:
Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial.

Circulation. 1993 Jan;87(1):38-52.

PRESENTATIONS

TIMI 3A Slides

OTHER PUBLICATIONS

Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 1994 Sep 15;74(6):531-7.